Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

QP pharmaceutical formulation and processing - part 1

28 May 2024 09:00 - 29 May 2024 17:00, Reading, United Kingdom


Introduction

Course Overview

The Qualified Person should have a thorough knowledge of formulation and processing of the medicinal products they are asked to certify.

The full course is structured over six-days and split into two parts. The course provides basic formulation principles, including preformulation studies, bioavailability considerations and the effect of excipients on physical and chemical stability. Each major product category is considered separately with respect to common formulations and processing techniques.

The course includes exercises on typical situations for the trainee QP to practice decision-making. Sessions on other key areas that a QP must understand including process validation and scale-up, facility design, utilities and sterilisation processes are included.

There is an optional laboratory practical day offered that enables delegates to gain hands-on experience in the preparation and evaluation of some formulations.

Who Should Attend

This is a crucial module for QPs who are, or who will be involved in certifying commercial or investigational batches of medicinal products. The course is most suitable for delegates with no prior or a basic knowledge of the subject however would be of benefit to the more experienced.
Venue
RSSL Training

RSSL Training, RSSL, Reading Science Centre, Whiteknights Campus, Pepper Road, Reading, RG6 6LA, United Kingdom

Contact information
RSSL Training
Reading Scientific Services Ltd
01189184076
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*